Methods of using integrin modulators for treatment of inflammation
US6177475A · kind A · utility
7Cited by
14References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 1997 |
| Grant date | Jan 23, 2001 |
| Priority date | — |
| Expiry date | May 12, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/17
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods of treating inflammatory diseases and conditions by administering an effective amount of an integrin modulating agent, as further defined and specified herein, to an animal suffering from one of the diseases or conditions. The preferred integrin modulating agents are ajoene and disintegrins, variants and analogs of disintegrins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.